Frontiers in Oncology (Aug 2022)

Fate decisions of breast cancer stem cells in cancer progression

  • Hui Xu,
  • Fengxia Zhang,
  • Xiaokang Gao,
  • Qiwang Zhou,
  • Linhai Zhu

DOI
https://doi.org/10.3389/fonc.2022.968306
Journal volume & issue
Vol. 12

Abstract

Read online

Breast cancer has a marked recurrence and metastatic trait and is one of the most prevalent malignancies affecting women’s health worldwide. Tumor initiation and progression begin after the cell goes from a quiescent to an activated state and requires different mechanisms to act in concert to regulate t a specific set of spectral genes for expression. Cancer stem cells (CSCs) have been proven to initiate and drive tumorigenesis due to their capability of self-renew and differentiate. In addition, CSCs are believed to be capable of causing resistance to anti-tumor drugs, recurrence and metastasis. Therefore, exploring the origin, regulatory mechanisms and ultimate fate decision of CSCs in breast cancer outcomes has far-reaching clinical implications for the development of breast cancer stem cell (BCSC)-targeted therapeutic strategies. In this review, we will highlight the contribution of BCSCs to breast cancer and explore the internal and external factors that regulate the fate of BCSCs.

Keywords